BRAF and malignant colon neoplasm: Samowitz et al. reported that the BRAF V600E mutation in MSS colon cancer was associated with a significantly poorer survival in stage II to IV colon cancer, but did not have an effect on the excellent prognosis of MSI tumors [57].